<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     naa a22        4500</leader>
  <controlfield tag="001">510799914</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180411083350.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">180411e20130201xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s12028-012-9797-7</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s12028-012-9797-7</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Goal Directed Brain Tissue Oxygen Monitoring Versus Conventional Management in Traumatic Brain Injury: An Analysis of In Hospital Recovery</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Joel Green, Daniela Pellegrini, Wayne Vanderkolk, Bryan Figueroa, Evert Eriksson]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Background: Brain tissue oxygen monitoring (pBtO2) has been advocated in the treatment of patients with severe traumatic brain injuries (TBI); however, controversy exists regarding the improvements that pBtO2 monitoring provides. The objective of our study was to evaluate our experience and effect on mortality with goal directed pBtO2 monitoring for severe TBI compared to traditional ICP/CPP monitoring. Methods: All patients admitted with severe TBI (GCS&lt;8) to our Level 1 trauma center from June 2007 through June 2009 were retrospectively analyzed. All patients had ICP monitoring and pBtO2 monitors were placed based on the current practices of the attending neurosurgeon producing two temporally matched cohorts of patients with and without pBtO2 monitors. Exclusion criteria were age &lt;18years and survival &lt;24h. Goal-directed therapy was utilized in all patients to maintain ICP &lt;20mmHg and CPP &gt;60mmHg. Patients with pBtO2 monitors were managed to maintain a level &gt;20mmHg. Results: 74 patients were treated for severe TBI over the 2-year study period with 37 patients in each group. Both groups were similar in age, sex, and admission Glascow Coma Score(GCS).The pBtO2-monitored group did, however, have significantly lower injury severity score [26 (25-30) vs. 30 (26-36), p=0.03] and AIS Chest [0 (0-0) vs. 2 (0-3), p=0.02]. There was no survival difference found (64.9 vs. 54.1%, p=0.34). No difference with respect to discharge GCS or discharge Functional Independence Measure score was identified. Conclusions: Compared with ICP/CPP-directed therapy alone, the addition of pBtO2 monitoring did not provide a survival or functional status improvement at discharge. The true clinical benefit of pBtO2 monitoring will require further study.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer Science+Business Media New York, 2012</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Trauma</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">pBtO2</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Traumatic brain injury</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Brain tissue oxygenation</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Intracranial pressure</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Intracranial monitor</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Outcome</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Green</subfield>
   <subfield code="D">Joel</subfield>
   <subfield code="u">Department of Trauma, Saint Mary's Health Care, Grand Rapids, MI, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Pellegrini</subfield>
   <subfield code="D">Daniela</subfield>
   <subfield code="u">Department of Internal Medicine, University of Wisconsin-Madison, Madison, WI, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Vanderkolk</subfield>
   <subfield code="D">Wayne</subfield>
   <subfield code="u">Department of Trauma, Saint Mary's Health Care, Grand Rapids, MI, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Figueroa</subfield>
   <subfield code="D">Bryan</subfield>
   <subfield code="u">Department of Neurosurgery, Spectrum Health, Grand Rapids, MI, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Eriksson</subfield>
   <subfield code="D">Evert</subfield>
   <subfield code="u">Department of General Surgery, Medical University of South Carolina, 96 Jonathan Lucas Street, Suite 420, 29425, Charleston, SC, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Neurocritical Care</subfield>
   <subfield code="d">Humana Press Inc</subfield>
   <subfield code="g">18/1(2013-02-01), 20-25</subfield>
   <subfield code="x">1541-6933</subfield>
   <subfield code="q">18:1&lt;20</subfield>
   <subfield code="1">2013</subfield>
   <subfield code="2">18</subfield>
   <subfield code="o">12028</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s12028-012-9797-7</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s12028-012-9797-7</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Green</subfield>
   <subfield code="D">Joel</subfield>
   <subfield code="u">Department of Trauma, Saint Mary's Health Care, Grand Rapids, MI, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Pellegrini</subfield>
   <subfield code="D">Daniela</subfield>
   <subfield code="u">Department of Internal Medicine, University of Wisconsin-Madison, Madison, WI, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Vanderkolk</subfield>
   <subfield code="D">Wayne</subfield>
   <subfield code="u">Department of Trauma, Saint Mary's Health Care, Grand Rapids, MI, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Figueroa</subfield>
   <subfield code="D">Bryan</subfield>
   <subfield code="u">Department of Neurosurgery, Spectrum Health, Grand Rapids, MI, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Eriksson</subfield>
   <subfield code="D">Evert</subfield>
   <subfield code="u">Department of General Surgery, Medical University of South Carolina, 96 Jonathan Lucas Street, Suite 420, 29425, Charleston, SC, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Neurocritical Care</subfield>
   <subfield code="d">Humana Press Inc</subfield>
   <subfield code="g">18/1(2013-02-01), 20-25</subfield>
   <subfield code="x">1541-6933</subfield>
   <subfield code="q">18:1&lt;20</subfield>
   <subfield code="1">2013</subfield>
   <subfield code="2">18</subfield>
   <subfield code="o">12028</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
